Literature DB >> 12138358

Radiocontrast-induced renal tubular cell apoptosis: hypertonic versus oxidative stress.

Istvan Hizoh1, Christlieb Haller.   

Abstract

RATIONALE AND
OBJECTIVES: Radiocontrast-induced nephropathy (RCIN) is a major complication of intravascular radiocontrast administration. Renal tubular cell apoptosis is a feature of RCIN, which is related to hypertonicity of contrast agents. Because a hyperosmolal extracellular environment induces oxidative stress via reactive oxygen species, we tested the hypothesis that antioxidants decrease hypertonicity-induced apoptosis of renal epithelial cells. We analyzed the effects of the antioxidants N-acetylcysteine (NAC) and taurine on hypertonicity-induced apoptosis of renal epithelial cells in vitro.
METHODS: Madin Darby Canine Kidney (MDCK) cells were incubated with the highly hyperosmolal, ionic radiocontrast agent diatrizoate (20% vol/vol, 6 hours) or with equally hyperosmolal (640 mOsm/kg) NaCl solutions. DNA fragmentation, which is a hallmark feature of apoptosis, was assessed quantitatively using flow cytometry after propidium iodide staining and qualitatively using agarose gel electrophoresis.
RESULTS: Both diatrizoate and NaCl induced DNA fragmentation in MDCK cells. Taurine (10 mmol/L) reduced DNA degradation in both diatrizoate- [79.5 +/- 2.3% versus 72.2 +/- 3.0%; P = 0.0088] and NaCl- [49.5 +/- 4.0% versus 39.4 +/- 1.0%; P = 0.0271] treated cells. In contrast, NAC (10 mmol/L) failed to reduce the DNA breakdown in this model of hypertonicity-induced renal tubular cell apoptosis.
CONCLUSIONS: The radiocontrast/hypertonicity-induced DNA fragmentation of MDCK cells is attenuated by taurine but not by NAC. Because both agents are antioxidants, the antioxidant property is not sufficient for the observed cytoprotective effect. Hence, the antiapoptotic effect of taurine has to be attributed to other, yet to be defined mechanisms. Our results suggest that pharmacological doses of taurine may be particularly protective against RCIN.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12138358     DOI: 10.1097/00004424-200208000-00003

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  30 in total

Review 1.  Gold nanoparticles: From nanomedicine to nanosensing.

Authors:  Po C Chen; Sandra C Mwakwari; Adegboyega K Oyelere
Journal:  Nanotechnol Sci Appl       Date:  2008-11-02

Review 2.  Functionalized upconversion nanoparticles: versatile nanoplatforms for translational research.

Authors:  F Chen; W Bu; W Cai; J Shi
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

3.  Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures.

Authors:  Alper O Onbasili; Yavuz Yeniceriglu; Pinar Agaoglu; Aslihan Karul; Tarkan Tekten; Harun Akar; Guzel Discigil
Journal:  Heart       Date:  2006-10-25       Impact factor: 5.994

4.  A prostacyclin analog prevents radiocontrast nephropathy via phosphorylation of cyclic AMP response element binding protein.

Authors:  Takahisa Yano; Yoshinori Itoh; Toshio Kubota; Toshiaki Sendo; Tatsuya Koyama; Takuya Fujita; Kumiko Saeki; Akira Yuo; Ryozo Oishi
Journal:  Am J Pathol       Date:  2005-05       Impact factor: 4.307

Review 5.  Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies.

Authors:  Ilan Goldenberg; Shlomi Matetzky
Journal:  CMAJ       Date:  2005-05-24       Impact factor: 8.262

6.  Serofendic acid protects from iodinated contrast medium and high glucose probably against superoxide production in LLC-PK1 cells.

Authors:  Osamu Kitamura; Kazuhide Uemura; Hisayo Kitamura; Hachiro Sugimoto; Akinori Akaike; Takahiko Ono
Journal:  Clin Exp Nephrol       Date:  2008-10-01       Impact factor: 2.801

7.  Taurine modulates neutrophil function but potentiates uropathogenic E. coli infection in the murine bladder.

Authors:  Claire Condron; Rowan G Casey; Siobhan Kehoe; Deirdre Toomey; Tom Creagh; David J Bouchier-Hayes
Journal:  Urol Res       Date:  2009-11-26

Review 8.  X-ray-computed tomography contrast agents.

Authors:  Hrvoje Lusic; Mark W Grinstaff
Journal:  Chem Rev       Date:  2012-12-05       Impact factor: 60.622

9.  Ischemia-Modified Albumin, Creatinine, And Paraoxonase-1 Levels in Serum of Patients Undergoing Intravenous Contrast-Enhanced Computed Tomography and Its Association with Contrast-Induced Nephropathy.

Authors:  Chanda Jha; Shobha Ullas Kamath; Sambit Dash; Ravindra Prabhu Attur; Lingadakai Ramachandra; Rajgopal Shenoy Kallya
Journal:  Rep Biochem Mol Biol       Date:  2019-04

10.  A novel approach to contrast-induced nephrotoxicity: the melatonergic agent agomelatine.

Authors:  Adem Karaman; Busra Diyarbakir; Irmak Durur-Subasi; Duygu Kose; Asli Özbek-Bilgin; Atilla Topcu; Cemal Gundogdu; Afak Durur-Karakaya; Zafer Bayraktutan; Fatih Alper
Journal:  Br J Radiol       Date:  2016-02-17       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.